Showing results (1881-1890 of 2,276) with videos related to
Sort By:
Pageof 228
Nature Communications|February 18, 2016
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpointsShohei Koyama, Esra A Akbay, Yvonne Y Li, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Quality assessment of genetic markers used for therapy stratificationI M Ambros, J Benard, M Boavida, et al.Molecular Cancer|March 16, 2024
Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effectsYufei Wang, Alicia Buck, Brandon Piel, et al.Cancer Discovery|February 16, 2021
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint BlockadeShengqing Stan Gu, Wubing Zhang, Xiaoqing Wang, et al.Cancer Discovery|June 28, 2017
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma TransitionCarlos R Gil Del Alcazar, Sung Jin Huh, Muhammad B Ekram, et al.Nature Immunology|July 29, 2025
PD-1 is requisite for skin TRM cell formation and specification by TGFβK Sanjana P Devi, Eric Wang, Abhinav Jaiswal, et al.Physical Review Letters|February 29, 2020
First Exploration of Neutron Shell Structure below Lead and beyond N=126T L Tang, B P Kay, C R Hoffman, et al.Oncoimmunology|June 15, 2018
TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomasTsuyoshi Hamada, Thing Rinda Soong, Yohei Masugi, et al.Nature|September 28, 2022
PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion programMasao Hashimoto, Koichi Araki, Maria A Cardenas, et al.Cancer Causes & Control : CCC|January 19, 2017
Proceedings of the third international molecular pathological epidemiology (MPE) meetingPeter T Campbell, Timothy R Rebbeck, Reiko Nishihara, et al.Pageof 228